Limb-girdle muscular dystrophy (LGMD) describes a group of rare genetic conditions affecting the hip and shoulder girdle muscles. LGMD typically causes muscle weakness and deterioration and can ...

Figure 1: Physical map of the candidate region for the LGMD 2G locus, showing approximate locations of 40 genetic markers. Figure 3: DNA sequence electrophoregrams representing the two mutations ...

Patients are often the best experts on their disease, but what about emergency situations? Columnist Patrick Moeschen shares ...

Others are so weak they need to use a wheelchair. In its later stages, limb-girdle muscular dystrophy can cause serious heart problems. Usually this type of muscular dystrophy doesn't appear until ...

“There are no disease-modifying treatments approved for patients with any subtype of limb-girdle muscular dystrophy, and the unmet medical need is significant. Following feedback from U.S ...

The U.S. Food and Drug Administration (FDA) granted platform technology designation to the viral vector used in SRP-9003, an ...

Muscular dystrophy is the overarching name for a group of illnesses that progressively cause a reduction in muscle mass and ...

Discover the various types, causes, symptoms, diagnosis, and treatments for muscular dystrophy, along with early warning ...

Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...

LANCASTER, Pa., Jan. 20, 2025 /PRNewswire/ -- On July 18, 2025, The Speak Foundation will host the fourth International Limb Girdle Muscular Dystrophy (LGMD) Conference at the J.W. Marriott ...